Diploma (LON:DPLM) Stock Price Up 0% – Time to Buy?

Shares of Diploma PLC (LON:DPLMGet Free Report) rose 0% during mid-day trading on Wednesday . The company traded as high as GBX 4,870 ($65.22) and last traded at GBX 4,862 ($65.11). Approximately 11,753,362 shares were traded during trading, an increase of 1,962% from the average daily volume of 570,027 shares. The stock had previously closed at GBX 4,860 ($65.09).

Diploma Price Performance

The company has a debt-to-equity ratio of 62.17, a current ratio of 2.17 and a quick ratio of 0.80. The stock’s fifty day simple moving average is GBX 3,949.28 and its 200-day simple moving average is GBX 4,253.28. The company has a market capitalization of £6.46 billion, a P/E ratio of 55.70, a PEG ratio of 2.82 and a beta of 0.75.

Diploma (LON:DPLMGet Free Report) last released its quarterly earnings results on Wednesday, May 21st. The company reported GBX 80.20 ($1.07) earnings per share (EPS) for the quarter. Diploma had a net margin of 9.25% and a return on equity of 13.18%. On average, equities analysts forecast that Diploma PLC will post 163.7995512 earnings per share for the current fiscal year.

Insider Activity at Diploma

In related news, insider David S. Lowden bought 750 shares of Diploma stock in a transaction that occurred on Friday, March 21st. The stock was acquired at an average price of GBX 3,928 ($52.60) per share, for a total transaction of £29,460 ($39,453.60). Also, insider Ian El-Mokadem bought 500 shares of Diploma stock in a transaction that occurred on Monday, March 24th. The stock was bought at an average price of GBX 3,948 ($52.87) per share, with a total value of £19,740 ($26,436.32). 0.52% of the stock is owned by corporate insiders.

Diploma Company Profile

(Get Free Report)

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.

Read More

Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.